These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24051434)

  • 21. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer.
    Low L; Mander A; McCann K; Dearnaley D; Tjelle T; Mathiesen I; Stevenson F; Ottensmeier CH
    Hum Gene Ther; 2009 Nov; 20(11):1269-78. PubMed ID: 19619001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.
    Kichaev G; Mendoza JM; Amante D; Smith TR; McCoy JR; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2013 Oct; 9(10):2041-8. PubMed ID: 23954979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine.
    Cheeseman HM; Day S; McFarlane LR; Fleck S; Miller A; Cole T; Sousa-Santos N; Cope A; Cizmeci D; Tolazzi M; Hwekwete E; Hannaman D; Kratochvil S; McKay PF; Chung AW; Kent SJ; Cook A; Scarlatti G; Abraham S; Combadiere B; McCormack S; Lewis DJ; Shattock RJ
    Hum Gene Ther; 2018 Sep; 29(9):1011-1028. PubMed ID: 30027768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
    Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
    Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.
    Ake JA; Schuetz A; Pegu P; Wieczorek L; Eller MA; Kibuuka H; Sawe F; Maboko L; Polonis V; Karasavva N; Weiner D; Sekiziyivu A; Kosgei J; Missanga M; Kroidl A; Mann P; Ratto-Kim S; Anne Eller L; Earl P; Moss B; Dorsey-Spitz J; Milazzo M; Laissa Ouedraogo G; Rizvi F; Yan J; Khan AS; Peel S; Sardesai NY; Michael NL; Ngauy V; Marovich M; Robb ML
    J Infect Dis; 2017 Nov; 216(9):1080-1090. PubMed ID: 28968759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
    Mpendo J; Mutua G; Nanvubya A; Anzala O; Nyombayire J; Karita E; Dally L; Hannaman D; Price M; Fast PE; Priddy F; Gelderblom HC; Hills NK
    PLoS One; 2020; 15(5):e0233151. PubMed ID: 32469893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Safety and Immunogenicity of GTU
    Haidari G; Day S; Wood M; Ridgers H; Cope AV; Fleck S; Yan C; Reijonen K; Hannaman D; Spentzou A; Hayes P; Vogt A; Combadiere B; Cook A; McCormack S; Shattock RJ
    Front Immunol; 2019; 10():2911. PubMed ID: 31921170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods.
    Wang S; Zhang C; Zhang L; Li J; Huang Z; Lu S
    Vaccine; 2008 Apr; 26(17):2100-10. PubMed ID: 18378365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroporation-mediated intradermal delivery of DNA vaccines in nonhuman primates.
    Adam L; Le Grand R; Martinon F
    Methods Mol Biol; 2014; 1121():309-13. PubMed ID: 24510834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation.
    Dolter KE; Evans CF; Ellefsen B; Song J; Boente-Carrera M; Vittorino R; Rosenberg TJ; Hannaman D; Vasan S
    Vaccine; 2011 Jan; 29(4):795-803. PubMed ID: 21094270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device.
    Amante DH; Smith TR; Mendoza JM; Schultheis K; McCoy JR; Khan AS; Sardesai NY; Broderick KE
    Hum Gene Ther Methods; 2015 Aug; 26(4):134-46. PubMed ID: 26222896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids.
    Chen H; Wen B; Deng Y; Wang W; Yin X; Guan J; Ruan L; Tan W
    Clin Vaccine Immunol; 2011 Nov; 18(11):1789-95. PubMed ID: 21900535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.
    Frenck RW; Belshe R; Brady RC; Winokur PL; Campbell JD; Treanor J; Hay CM; Dekker CL; Walter EB; Cate TR; Edwards KM; Hill H; Wolff M; Leduc T; Tornieporth N
    Vaccine; 2011 Aug; 29(34):5666-74. PubMed ID: 21699951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    Forster AH; Witham K; Depelsenaire ACI; Veitch M; Wells JW; Wheatley A; Pryor M; Lickliter JD; Francis B; Rockman S; Bodle J; Treasure P; Hickling J; Fernando GJP
    PLoS Med; 2020 Mar; 17(3):e1003024. PubMed ID: 32181756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delineating the Cellular Mechanisms Associated with Skin Electroporation.
    Schultheis K; Smith TRF; Kiosses WB; Kraynyak KA; Wong A; Oh J; Broderick KE
    Hum Gene Ther Methods; 2018 Aug; 29(4):177-188. PubMed ID: 29953259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
    Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
    Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.
    Hutnick NA; Myles DJ; Ferraro B; Lucke C; Lin F; Yan J; Broderick KE; Khan AS; Sardesai NY; Weiner DB
    Hum Gene Ther; 2012 Sep; 23(9):943-50. PubMed ID: 22650607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.